Eosinophil count testing in patients with asthma varies by healthcare provider type in the US: a retrospective study
The prevalence of blood eosinophil count testing in patients with asthma remains suboptimal. Routine blood eosinophil count testing should be considered by HCPs for patients with asthma to increase identification of the eosinophilic asthma phenotype, which may inform the decision to advance to targeted biologic therapy.
Authors
- Thomas Corbridge
- Krutika Jariwala‐Parikh
- Sameer K. Mathur (ORCID: https://orcid.org/0000-0001-7656-0256)
- Arijita Deb (ORCID: https://orcid.org/0000-0002-4570-0364)
- Elizabeth Packnett (ORCID: https://orcid.org/0000-0002-4731-6956)
Institutions
- University of Wisconsin–Madison (US)
- Providence College (US)
- Glaxosmithkline (Finland) (FI)
- Durham VA Medical Center (US)
Publication Details
- Journal
- Allergy Asthma and Clinical Immunology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1186/s13223-024-00917-4
- Citations
- 1
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.33